PRENATE DHA description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

PRENATE DHA

Avion Pharmaceuticals, LLC

DHA


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Rx prenatal vitamin & DHA
With

Quatrefolic®

Rx Only

DESCRIPTION: PRENATE DHA® is a prescription prenatal/postnatal multivitamin/mineral/essential fatty acid softgel. Each softgel is blue in color, opaque, and imprinted with “DHA” on one side and blank on the other.

Supplement Facts
Serving Size: 1 Softgel
Amount per Serving: % Daily Value % Daily Value for
Lactating Women
Vitamin C (as ascorbic acid) 90 mg 150% 150%
Vitamin D3 (as cholecalciferol) 220 IU 55% 55%
Vitamin E (as dl-alpha tocopherol) 10 IU 33% 33%
Vitamin B6 (as pyridoxine HCl) 26 mg 1300% 1040%
Folate
(as 1.1 mg Quatrefolic® ((6S)-5,methyltetrahydrofolate glucosamine salt* CAS 1181972-37-1) molar equivalent to 600 mcg of Folic Acid) (folic acid, USP 400 mcg)
1 mg 250% 125%
Vitamin B12 (as cyanocobalamin) 13 mcg 217% 163%
Calcium (as calcium carbonate) 145 mg 15% 11%
Iron (as ferrous fumarate) 28 mg 156% 156%
Magnesium (as magnesium oxide) 50 mg 13% 11%
Docosahexaenoic Acid (DHA)
(from omega-3 fatty acids from fish oil)
300 mg Daily Value (DV) not established. Daily Value (DV) not established.

PRENATE DHA® contains fish oil and soy.

OTHER INGREDIENTS: bee’s wax, hydrogenated vegetable oil, soy lecithin, gelatin, glycerin, purified water, titanium dioxide, FD&C Blue #1 and FD&C Red #3.

Uses

INDICATIONS: PRENATE DHA® is a multivitamin/multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.

PRENATE DHA® can also be beneficial in improving the nutritional status of women prior to conception.

CONTRAINDICATIONS: PRENATE DHA® is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING: Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.

PRECAUTIONS: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

DOSAGE AND ADMINISTRATION: Before, during and/or after pregnancy, one softgel daily or as directed by a physician.

HOW SUPPLIED: Unit-dose packs of 30 softgels. (75854-302-30).

The listed product number is not a National Drug Code, but has instead merely been formatted to comply with standard industry practice for pharmacy and insurance computer systems.

Store at 20° - 25°C (68° - 77°F); excursions permitted to 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature.]

MANUFACTURED FOR: Avion Pharmaceuticals, LLC
Atlanta, GA 30350
1-888-61-AVION

*Quatrefolic® is a registered trademark of Gnosis, SpA.Covered by one or more claims of U.S. Patent # 7,947,662 CAS# 1181972-37-1

PRENATE DHA® is a registered trademark of Acella Pharmaceuticals, LLC.
Under license from Acella Pharmaceuticals, LLC.
All rights reserved.

Rev. 021412

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

75854-302-30         30 Softgels

Prenate
Rx prenatal vitamin &
DHA®

with
Quatrefolic®

• Key vitamins, minerals, and DHA support nutrition

Long lasting stability
Improved bioavailability
High water solubility
Established safety

Quatrefolic®            Rx Only

Prenate DHA is a registered trademark of Acella Pharmaceuticals, LLC.
*Quatrefolic® is a registered trademark of Gnosis, SpA. Covered by one or more claims of U.S. Patent # 7,947,662 CAS# 1181972-37-1
Under license from Acella Pharmaceuticals, LLC.
All rights reserved.

PRENATE DHA

PRENATE DHA

ascorbic acid, cholecalciferol, .alpha.-tocopherol, dl-, pyridoxine hydrochloride, folic acid, cyanocobalamin, calcium carbonate, ferrous fumarate, magnesium oxide and doconexent CAPSULE, GELATIN COATED

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:75854-302
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ASCORBIC ACID ASCORBIC ACID 90 mg
CHOLECALCIFEROL CHOLECALCIFEROL 220 [iU]
.ALPHA.-TOCOPHEROL, DL- 10 [iU]
PYRIDOXINE HYDROCHLORIDE PYRIDOXINE 26 mg
FOLIC ACID FOLIC ACID 1 mg
Cyanocobalamin CYANOCOBALAMIN 13 ug
CALCIUM CARBONATE 145 mg
FERROUS FUMARATE FERROUS CATION 28 mg
magnesium oxide 50 mg
DOCONEXENT DOCONEXENT 300 mg

Inactive Ingredients

Ingredient Name Strength
YELLOW WAX
CORN OIL
LECITHIN, SOYBEAN
GELATIN
GLYCERIN
water
titanium dioxide
FD&C BLUE NO. 1
FD&C RED NO. 3

Product Characteristics

Color Size Imprint Code Shape
YELLOW (opaque) 24 mm DHA OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 30 in 1 BLISTER PACK
2 NDC:75854-302-30 30 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2012-01-31


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.